Derivative Suit Says Biotech Co. Lied About COVID-19 Vaccine
An investor of biotechnology company Vaxart has accused the company's officers of enriching themselves and artificially inflating stock prices by lying about receiving government funding to develop a COVID-19 vaccine, according...To view the full article, register now.
Already a subscriber? Click here to view full article